13th Tetrahedron Symposium (Asia) – Challenges in Bioorganic & Organic Medicinal Chemistry
Symposium - Taipei, Taiwan
Sequencing nucleic acids: from chemistry to life sciences and medicine
Tuberculosis drug discovery: continuing to fail in good spirits
Oligonucleotide-based tools for pharmacology and nano-engineering
The future of kinase drug discovery - challenges and opportunities
Fragment-based drug discovery: a decade of thinking small
Modulation of DNA damage-response pathways in cancer therapy
The chemical biology of protein splicing
Molecular design for selective recognition and reaction with RNA
Target identification for biologically relevant small molecules
Direct Transformation of Unreactive ChemicalBonds
Total Synthesis as a Vehicle for Interrogating Biosynthetic and Biomechanistic Puzzles
![Tetra Symposium Asia 2012 Leaderboard[1] resized 600](http://cdn2.hubspot.net/hub/45279/file-14336704-gif/images/tetra-symposium-asia-2012-leaderboard[1]-resized-600.gif?width=480&height=62&name=tetra-symposium-asia-2012-leaderboard[1]-resized-600.gif)
(Photo courtesy of http://www.tetrahedronsymposiumasia.com/index.html)
27 - 30 November 2012
Taipei, Taiwan
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
